A vs ARKG: Which Stock is Better?
Side-by-side comparison of Agilent Technologies Inc and Ark Genomic Revolution Etf in 2026
A
Agilent Technologies Inc
$118.25
ARKG
Ark Genomic Revolution Etf
$29.84
Key Metrics Comparison
| Metric | A | ARKG | Winner |
|---|---|---|---|
| Market Cap | $33.88B | N/A | A |
| P/E Ratio | 26.62 | N/A | A |
| EPS (TTM) | $4.50 | $N/A | A |
| Revenue Growth | 0.1% | 0.0% | A |
| Gross Margin | 52.3% | 0.0% | A |
Analyze A
Full quant analysis
Analyze ARKG
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is A or ARKG a better investment?
Comparing A and ARKG: Agilent Technologies Inc has a market cap of $33.88B while Ark Genomic Revolution Etf has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between A and ARKG?
A (Agilent Technologies Inc) and ARKG (Ark Genomic Revolution Etf) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: A or ARKG?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: A or ARKG?
A has higher revenue growth at 0.1% vs 0.0% for ARKG.
Which company is more profitable: A or ARKG?
Agilent Technologies Inc (A) has higher gross margins at 52.3% compared to 0.0% for ARKG.
Which is the larger company: A or ARKG?
Agilent Technologies Inc (A) is larger with a market cap of $33.88B compared to N/A for ARKG.
Should I buy A or ARKG in 2026?
Both A and ARKG have investment merit. A trades at $118.25 while ARKG trades at $29.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between A and ARKG stock?
Key differences: Market Cap ($33.88B vs N/A), P/E Ratio (26.6x vs N/A), Revenue Growth (0.1% vs 0.0%), Gross Margin (52.3% vs 0.0%).